This Article Full Text Full Text (PDF) All Versions of this Article: 108/13/1633    most recent 01.CIR.0000087595.17277.73v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xiao, R.-P. Articles by Cheng, H. Search for Related Content PubMed PubMed Citation Articles by Xiao, R.-P. Articles by Cheng, H. Related Collections Heart failure - basic studies

(Circulation. 2003;108:1633.)
© 2003 American Heart Association, Inc.

Basic Science Reports

Enhanced G_i Signaling Selectively Negates ß₂-Adrenergic Receptor (AR)– but Not ß₁-AR–Mediated Positive Inotropic Effect in Myocytes From Failing Rat Hearts

Rui-Ping Xiao, MD, PhD; Sheng-Jun Zhang, MD; Khalid Chakir, PhD; Pavel Avdonin, PhD; Weizhong Zhu, MD, PhD; Richard A. Bond, PhD; C. William Balke, MD, PhD; Edward G. Lakatta, MD; Heping Cheng, PhD

From the Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, Md (R.X., S.Z., K.C., P.A., W.Z., E.G.L., H.C.); the Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, Tex (R.A.B.); and the Departments of Physiology and Medicine, University of Maryland at Baltimore, and Department of Medicine, Johns Hopkins University, School of Medicine, Baltimore, Md (C.W.B.).

Correspondence to Rui-Ping Xiao, MD, PhD, Laboratory of Cardiovascular Science, Gerontology Research Center, NIA, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224. E-mail xiaor{at}grc.nia.nih.gov

Received January 15, 2003; revision received May 20, 2003; accepted May 21, 2003.

Background— Myocardial contractile response to ß₁- and ß₂-adrenergic receptor (AR) stimulation is severely impaired in chronic heart failure, in which G_i signaling and the ratio of ß₂/ß₁ are often increased. Because ß₂-AR but not ß₁-AR couples to G_s and G_i with the G_i coupling negating the G_s-mediated contractile response, we determined whether the heart failure–associated augmentation of G_i signaling contributes differentially to the defects of these ß-AR subtypes and, if so, whether inhibition of G_i or selective activation of ß₂-AR/G_s by ligands restores ß₂-AR contractile response in the failing heart.

Methods and Results— Cardiomyocytes were isolated from 18- to 24-month-old failing spontaneously hypertensive (SHR) or age-matched Wistar-Kyoto (WKY) rat hearts. In SHR cardiomyocytes, either ß-AR subtype–mediated inotropic effect was markedly diminished, whereas G_i proteins and the ß₂/ß₁ ratio were increased. Disruption of G_i signaling by pertussis toxin (PTX) enabled ß₂- but not ß₁-AR to induce a full positive inotropic response in SHR myocytes. Furthermore, screening of a panel of ß₂-AR ligands revealed that the contractile response mediated by most ß₂-AR agonists, including zinterol, salbutamol, and procaterol, was potentiated by PTX, indicating concurrent G_s and G_i activation. In contrast, fenoterol, another ß₂-AR agonist, induced a full positive inotropic effect in SHR myocytes even in the absence of PTX.

Conclusions— We conclude that enhanced G_i signaling is selectively involved in the dysfunction of ß₂- but not ß₁-AR in failing SHR hearts and that disruption of G_i signaling by PTX or selective activation of ß₂-AR/G_s signaling by fenoterol restores the blunted ß₂-AR contractile response in the failing heart.

Key Words: receptors, adrenergic, beta • heart failure • proteins • contractility

This article has been cited by other articles:

				J. DeSantiago, X. Ai, M. Islam, G. Acuna, M. T. Ziolo, D. M. Bers, and S. M. Pogwizd Arrhythmogenic Effects of {beta}2-Adrenergic Stimulation in the Failing Heart Are Attributable to Enhanced Sarcoplasmic Reticulum Ca Load Circ. Res., June 6, 2008; 102(11): 1389 - 1397. [Abstract] [Full Text] [PDF]

				C. Wang, J.-F. Du, F. Wu, and H.-C. Wang Apelin decreases the SR Ca2+ content but enhances the amplitude of [Ca2+]i transient and contractions during twitches in isolated rat cardiac myocytes Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2540 - H2546. [Abstract] [Full Text] [PDF]

				L. P. Collis, S. Srivastava, W. A. Coetzee, and M. Artman beta2-Adrenergic receptor agonists stimulate L-type calcium current independent of PKA in newborn rabbit ventricular myocytes Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2826 - H2835. [Abstract] [Full Text] [PDF]

				X.-H. Zhang, G.-R. Li, and J.-P. Bourreau The effect of adrenomedullin on the L-type calcium current in myocytes from septic shock rats: signaling pathway Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2888 - H2893. [Abstract] [Full Text] [PDF]

				S. Galandrin and M. Bouvier Distinct Signaling Profiles of beta1 and beta2 Adrenergic Receptor Ligands toward Adenylyl Cyclase and Mitogen-Activated Protein Kinase Reveals the Pluridimensionality of Efficacy Mol. Pharmacol., November 1, 2006; 70(5): 1575 - 1584. [Abstract] [Full Text] [PDF]

				J. G. Burniston, L.-B. Tan, and D. F. Goldspink Relative myotoxic and haemodynamic effects of the {beta}-agonists fenoterol and clenbuterol measured in conscious unrestrained rats Exp Physiol, November 1, 2006; 91(6): 1041 - 1049. [Abstract] [Full Text] [PDF]

				J. T. Hulme, R. E. Westenbroek, T. Scheuer, and W. A. Catterall Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1-adrenergic regulation PNAS, October 31, 2006; 103(44): 16574 - 16579. [Abstract] [Full Text] [PDF]

				S. Mittra and J.-P. Bourreau Gs and Gi coupling of adrenomedullin in adult rat ventricular myocytes Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1842 - H1847. [Abstract] [Full Text] [PDF]

				Z.-S. Zhang, H.-J. Cheng, K. Onishi, N. Ohte, T. Wannenburg, and C.-P. Cheng Enhanced Inhibition of L-type Ca2+ Current by {beta}3-Adrenergic Stimulation in Failing Rat Heart J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1203 - 1211. [Abstract] [Full Text] [PDF]

				W. Zhu, X. Zeng, M. Zheng, and R.-P. Xiao The Enigma of {beta}2-Adrenergic Receptor Gi Signaling in the Heart: The Good, the Bad, and the Ugly Circ. Res., September 16, 2005; 97(6): 507 - 509. [Full Text] [PDF]

				J.-Q. He, R. C. Balijepalli, R. A. Haworth, and T. J. Kamp Crosstalk of {beta}-Adrenergic Receptor Subtypes Through Gi Blunts {beta}-Adrenergic Stimulation of L-Type Ca2+ Channels in Canine Heart Failure Circ. Res., September 16, 2005; 97(6): 566 - 573. [Abstract] [Full Text] [PDF]

				W.-Z. Zhu, K. Chakir, S. Zhang, D. Yang, C. Lavoie, M. Bouvier, T. E. Hebert, E. G. Lakatta, H. Cheng, and R.-P. Xiao Heterodimerization of {beta}1- and {beta}2-Adrenergic Receptor Subtypes Optimizes {beta}-Adrenergic Modulation of Cardiac Contractility Circ. Res., August 5, 2005; 97(3): 244 - 251. [Abstract] [Full Text] [PDF]

				I. Ahmet, M. Krawczyk, P. Heller, C. Moon, E. G. Lakatta, and M. I. Talan Beneficial Effects of Chronic Pharmacological Manipulation of {beta}-Adrenoreceptor Subtype Signaling in Rodent Dilated Ischemic Cardiomyopathy Circulation, August 31, 2004; 110(9): 1083 - 1090. [Abstract] [Full Text] [PDF]

				A. Morimoto, H. Hasegawa, H.-J. Cheng, W. C. Little, and C.-P. Cheng Endogenous {beta}3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2425 - H2433. [Abstract] [Full Text] [PDF]

				J. F. Heubach, U. Ravens, and A. J. Kaumann Epinephrine Activates Both Gs and Gi Pathways, but Norepinephrine Activates Only the Gs Pathway through Human {beta}2-Adrenoceptors Overexpressed in Mouse Heart Mol. Pharmacol., May 1, 2004; 65(5): 1313 - 1322. [Abstract] [Full Text]